Clinical Trial Update: Obatoclax for Systemic Mastocytosis [Phase 2]

View source ↗

Summary

Phase 2 trial of obatoclax for systemic mastocytosis (with leukemia) was terminated; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Systemic Mastocytosis

Drugs mentioned

• Obatoclax (obatoclax mesylate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Systemic Mastocytosis | Phase 2 | Status: TERMINATED | Results posted: 2011-04-25